C
Cyclopharm Ltd
ASX:CYC
Cyclopharm Ltd
ASX:CYC
Price:
1.75 AUD
Market Closed
Updated:
Apr 29, 2024
Cyclopharm Ltd
Cash from Operating Activities
|
Cyclopharm Ltd
Cash from Operating Activities Peer Comparison
Comparables:
NTI
IPD
COH
OIL
EMV
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Operating Activities
-AU$7.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Operating Activities
-AU$6.3m
|
CAGR 3-Years
-110%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Operating Activities
-AU$12.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-8%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Operating Activities
AU$430.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
19%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Operating Activities
-AU$5.6m
|
CAGR 3-Years
-115%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-23%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Operating Activities
AU$834.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cyclopharm Ltd's Cash from Operating Activities?
Cash from Operating Activities
-7.2m
AUD
-7.2m
AUD
Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Cash from Operating Activities amounts to -7.2m AUD.
What is Cyclopharm Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-45%
-45%
Over the last year, the Cash from Operating Activities growth was -8%. The average annual Cash from Operating Activities growth rates for Cyclopharm Ltd have been 7% over the past three years , -45% over the past five years .
You don't have any saved screeners yet
